0001437749-23-021186.txt : 20230731 0001437749-23-021186.hdr.sgml : 20230731 20230731164336 ACCESSION NUMBER: 0001437749-23-021186 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20230725 ITEM INFORMATION: Changes in Registrant's Certifying Accountant ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20230731 DATE AS OF CHANGE: 20230731 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SAB Biotherapeutics, Inc. CENTRAL INDEX KEY: 0001833214 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 853899721 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39871 FILM NUMBER: 231127928 BUSINESS ADDRESS: STREET 1: 2100 EAST 54TH STREET NORTH CITY: SIOUX FALLS STATE: SD ZIP: 57104 BUSINESS PHONE: 605-679-6980 MAIL ADDRESS: STREET 1: 2100 EAST 54TH STREET NORTH CITY: SIOUX FALLS STATE: SD ZIP: 57104 FORMER COMPANY: FORMER CONFORMED NAME: Big Cypress Acquisition Corp. DATE OF NAME CHANGE: 20201120 8-K 1 sabs20230728_8k.htm FORM 8-K sabs20230728_8k.htm
false 0001833214 0001833214 2023-07-25 2023-07-25 0001833214 sabs:CommonStock00001ParValuePerShareCustomMember 2023-07-25 2023-07-25 0001833214 sabs:WarrantsEachExercisableForOneShareOfCommonStockAtAnExercisePriceOf1150PerShareCustomMember 2023-07-25 2023-07-25
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): July 25, 2023
 
SAB BIOTHERAPEUTICS, INC.
(Exact name of Registrant as Specified in Its Charter)
 
 
Delaware
001-39871
85-3899721
(State or Other Jurisdiction
of Incorporation)
(Commission File Number)
(IRS Employer
Identification No.)
     
2100 East 54th Street North
  
Sioux Falls, South Dakota
  
57104
(Address of Principal Executive Offices)
  
(Zip Code)
 
Registrant’s Telephone Number, Including Area Code: 605 679-6980
 
(Former Name or Former Address, if Changed Since Last Report)
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
  
Trading
Symbol(s)
  
Name of each exchange on which registered
Common stock, $0.0001 par value per share
  
SABS
  
The NASDAQ Stock Market LLC
Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share
  
SABSW
  
The NASDAQ Stock Market LLC
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
 
Emerging growth company ☒
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 
 
 
 
Item 4.01 Changes in Registrant’s Certifying Accountant.
 
On July 25, 2023, Mayer Hoffman McCann P.C. (“MHM”) informed SAB Biotherapeutics, Inc. (the “Company”) and the Audit Committee of the Company’s Board of Directors that it would not stand for re-election as the Company’s independent registered public accounting firm for the audit of the Company’s financial statements for the fiscal year ending December 31, 2023. MHM will cease to serve as the Company’s independent registered public accounting firm on the earlier of the date a new firm is engaged, the date of the filing of the Company’s Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2023, or August 21, 2023.
 
MHM is not required to and did not seek the Company’s consent to its decision to resign as the Company’s independent registered public accounting firm. As a result, neither the Company’s Board of Directors nor the Company’s Audit Committee took part in MHM’s decision to resign. The Company is in the process of selecting a new independent registered public accounting firm.
 
MHM audited the Company’s consolidated financial statements as of and for the fiscal years ended December 31, 2022 and 2021. MHM’s report, dated April 14, 2023, with respect to the consolidated financial statements of SAB Biotherapeutics, Inc. and Subsidiaries as of December 31, 2022 and 2021 and for each of the years ended December 31, 2022 and December 31, 2021 (i) did not contain any adverse opinion or disclaimer of opinion and were not qualified or modified as to uncertainty, audit scope or accounting principles, except that such report contained an explanatory paragraph in respect to uncertainty as to the Company’s ability to continue as a going concern and, (ii) did not advise the Company of any “reportable events” within the meaning of Item 304(a)(1)(v) of Regulation S-K with respect to the Company other than in connection with management’s conclusions in its annual report on Form 10-K for the fiscal year ended December 31, 2022, filed with the U.S. Securities and Exchange Commission (the “Commission”) on April 14, 2023 (as amended), that the Company did not design appropriate review controls surrounding technical accounting matters and significant and/or unusual transactions, which resulted in a material error that was corrected through the restatement of the Company’s consolidated financial statements as of and for the year ended December 31, 2021, and the correction of the unaudited quarterly financial information for period endings March 31, 2022, June 30, 2022, and September 30, 2022.
 
The Company provided MHM with a copy of this Current Report on Form 8-K in accordance with Item 304(a) of Regulation S-K prior to its filing with the Commission and requested that MHM furnish the Company with a letter addressed to the Commission stating whether it agrees with the above statements and, if it does not agree, the respects in which it does not agree. A copy of the letter from MHM is filed as Exhibit 16.1 hereto.
 
Item 9.01 Financial Statements and Exhibits.
 
Exhibit Number
Description
16.1
 Letter from Mayer Hoffman McCann P.C. to the Securities and Exchange Commission dated July 31, 2023.
104
Cover Page Interactive Data File-the cover page XBRL tags are embedded within the Inline XBRL document.
 
 
 
 
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
     
SAB Biotherapeutics, Inc.
       
Date:
July 31, 2023
By:
/s/ Eddie J. Sullivan
     
Eddie J. Sullivan
Chief Executive Officer
 
 
 EX-16.1 2 ex_550342.htm EXHIBIT 16.1 - LETTER FROM MAYER HOFFMAN MCCANN P.C. TO THE SECURITIES AND EXCHANGE COMMISSION DATED JULY 28, 2023. ex_550342.htm

Exhibit 16.1

 

July 31, 2023

 

Securities and Exchange Commission

100 F Street N.E.

Washington, D.C. 20549

 

Commissioners:

 

We have read Item 4.01 of SAB Biotherapeutics, Inc.’s Form 8-K dated July 31, 2023, and we agree with the statements set forth in Item 4.01, insofar as they relate to our firm. We have no basis to agree or disagree with other statements of the registrant contained therein.

 

Very truly yours,

 

/s/ Mayer Hoffman McCann P.C.

 

San Diego, California

 
 EX-101.SCH 3 sabs-20230725.xsd XBRL TAXONOMY EXTENSION SCHEMA 000 - Document - Document And Entity Information link:calculationLink link:definitionLink link:presentationLink EX-101.DEF 4 sabs-20230725_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 5 sabs-20230725_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Entity [Domain] Legal Entity [Axis] Document Information [Line Items] Document Information [Table] Document, Type Document, Period End Date Entity, Registrant Name Entity, Incorporation, State or Country Code Entity, File Number Entity, Tax Identification Number Entity, Address, Address Line One Entity, Address, City or Town Entity, Address, State or Province Entity, Address, Postal Zip Code City Area Code Local Phone Number Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security Trading Symbol Security Exchange Name Entity, Emerging Growth Company Entity, Ex Transition Period Amendment Flag Entity, Central Index Key Class of Stock [Axis] Class of Stock [Domain] CommonStock00001ParValuePerShare Custom [Member] WarrantsEachExercisableForOneShareOfCommonStockAtAnExercisePriceOf1150PerShare Custom [Member] EX-101.PRE 6 sabs-20230725_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 7 R1.htm IDEA: XBRL DOCUMENT v3.23.2
Document And Entity Information
Jul. 25, 2023
Document Information [Line Items]  
Entity, Registrant Name SAB BIOTHERAPEUTICS, INC.
Document, Type 8-K
Document, Period End Date Jul. 25, 2023
Entity, Incorporation, State or Country Code DE
Entity, File Number 001-39871
Entity, Tax Identification Number 85-3899721
Entity, Address, Address Line One 2100 East 54th Street North
Entity, Address, City or Town Sioux Falls
Entity, Address, State or Province SD
Entity, Address, Postal Zip Code 57104
City Area Code 605
Local Phone Number 679-6980
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity, Emerging Growth Company true
Entity, Ex Transition Period false
Amendment Flag false
Entity, Central Index Key 0001833214
CommonStock00001ParValuePerShare Custom [Member]  
Document Information [Line Items]  
Title of 12(b) Security Common stock, $0.0001 par value per share
Trading Symbol SABS
Security Exchange Name NASDAQ
WarrantsEachExercisableForOneShareOfCommonStockAtAnExercisePriceOf1150PerShare Custom [Member]  
Document Information [Line Items]  
Title of 12(b) Security Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share
Trading Symbol SABSW
Security Exchange Name NASDAQ
XML 8 sabs20230728_8k_htm.xml IDEA: XBRL DOCUMENT 0001833214 2023-07-25 2023-07-25 0001833214 sabs:CommonStock00001ParValuePerShareCustomMember 2023-07-25 2023-07-25 0001833214 sabs:WarrantsEachExercisableForOneShareOfCommonStockAtAnExercisePriceOf1150PerShareCustomMember 2023-07-25 2023-07-25 false 0001833214 8-K 2023-07-25 SAB BIOTHERAPEUTICS, INC. DE 001-39871 85-3899721 2100 East 54th Street North Sioux Falls SD 57104 605 679-6980 false false false false Common stock, $0.0001 par value per share SABS NASDAQ Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share SABSW NASDAQ true false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.2 html 3 23 1 false 2 0 false 0 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.sabs.com/20230725/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false All Reports Book All Reports sabs20230728_8k.htm ex_550342.htm sabs-20230725.xsd sabs-20230725_def.xml sabs-20230725_lab.xml sabs-20230725_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "sabs20230728_8k.htm": { "axisCustom": 0, "axisStandard": 1, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 26 }, "contextCount": 3, "dts": { "definitionLink": { "local": [ "sabs-20230725_def.xml" ] }, "inline": { "local": [ "sabs20230728_8k.htm" ] }, "labelLink": { "local": [ "sabs-20230725_lab.xml" ] }, "presentationLink": { "local": [ "sabs-20230725_pre.xml" ] }, "schema": { "local": [ "sabs-20230725.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/currency/2023/currency-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/exch/2023/exch-2023.xsd", "https://xbrl.sec.gov/sic/2023/sic-2023.xsd", "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" ] } }, "elementCount": 31, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2023": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 23, "memberCustom": 2, "memberStandard": 0, "nsprefix": "sabs", "nsuri": "http://www.sabs.com/20230725", "report": { "R1": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "sabs20230728_8k.htm", "contextRef": "d20238K", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000 - Document - Document And Entity Information", "menuCat": "Cover", "order": "1", "role": "http://www.sabs.com/20230725/role/statement-document-and-entity-information", "shortName": "Document And Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "sabs20230728_8k.htm", "contextRef": "d20238K", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 2, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.sabs.com/20230725/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.sabs.com/20230725/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.sabs.com/20230725/role/statement-document-and-entity-information" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2023", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document, Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.sabs.com/20230725/role/statement-document-and-entity-information" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document, Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.sabs.com/20230725/role/statement-document-and-entity-information" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity, Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.sabs.com/20230725/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity, Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.sabs.com/20230725/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity, Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.sabs.com/20230725/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity, Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.sabs.com/20230725/role/statement-document-and-entity-information" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity, Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.sabs.com/20230725/role/statement-document-and-entity-information" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.", "label": "Entity [Domain]" } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.sabs.com/20230725/role/statement-document-and-entity-information" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity, Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.sabs.com/20230725/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity, Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.sabs.com/20230725/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity, File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.sabs.com/20230725/role/statement-document-and-entity-information" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity, Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.sabs.com/20230725/role/statement-document-and-entity-information" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity, Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.sabs.com/20230725/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity, Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.sabs.com/20230725/role/statement-document-and-entity-information" ], "xbrltype": "employerIdItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.sabs.com/20230725/role/statement-document-and-entity-information" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.sabs.com/20230725/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.sabs.com/20230725/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.sabs.com/20230725/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.sabs.com/20230725/role/statement-document-and-entity-information" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.sabs.com/20230725/role/statement-document-and-entity-information" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.sabs.com/20230725/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.sabs.com/20230725/role/statement-document-and-entity-information" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.sabs.com/20230725/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "sabs_CommonStock00001ParValuePerShareCustomMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CommonStock00001ParValuePerShare Custom [Member]" } } }, "localname": "CommonStock00001ParValuePerShareCustomMember", "nsuri": "http://www.sabs.com/20230725", "presentation": [ "http://www.sabs.com/20230725/role/statement-document-and-entity-information" ], "xbrltype": "domainItemType" }, "sabs_WarrantsEachExercisableForOneShareOfCommonStockAtAnExercisePriceOf1150PerShareCustomMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "WarrantsEachExercisableForOneShareOfCommonStockAtAnExercisePriceOf1150PerShare Custom [Member]" } } }, "localname": "WarrantsEachExercisableForOneShareOfCommonStockAtAnExercisePriceOf1150PerShareCustomMember", "nsuri": "http://www.sabs.com/20230725", "presentation": [ "http://www.sabs.com/20230725/role/statement-document-and-entity-information" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.sabs.com/20230725/role/statement-document-and-entity-information" ], "xbrltype": "domainItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://www.sabs.com/20230725/role/statement-document-and-entity-information" ], "xbrltype": "stringItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r7": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 15 0001437749-23-021186-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001437749-23-021186-xbrl.zip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